Skip to main content
TipRanks
Go Ultimate75% OFF

iSpecimen (ISPC) Stock Price & Analysis

305 Followers

ISPC Stock Chart & Stats

$0.60-$0.01(-1.32%)
At close: 4:00 PM EST
$0.5$1$1.5$2Aug 24Sep 8Sep 21Oct 5Oct 19Nov 2Nov 16
Day’s Range
$0.56 - $0.60
52-Week Range
$0.56 - $27.45
Previous Close
$0.60
Volume
N/A
Average Volume (3M)
212.70K
Market Cap
$3.45M
Enterprise Value
-$478.08K
Total Cash (Recent Filing)
$4.41M
Total Debt (Recent Filing)
$240.90K
Price to Earnings (P/E)
―
Beta
1.49
Next Earnings
Mar 17, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Low Leverage

Low debt relative to equity reduces near-term interest and repayment pressure, giving iSpecimen more flexibility than a highly leveraged company. This cushion could help management fund operations or strategic initiatives while it works to improve weak earnings and cash generation.

AI Capability Expansion

Adding disease-intelligence software and models broadens iSpecimen beyond biospecimen fulfillment and could increase the usefulness of its healthcare network. If integrated effectively, the combined offering may support higher-value research workflows and create additional commercial opportunities.

Biospecimen Marketplace Model

A platform connecting specimen providers with multiple research customer groups can address a specialized sourcing problem while supporting repeat transactions and data-enabled services. The model also gives iSpecimen a basis for combining biospecimens, logistics, compliance, and clinical information.

Bears Say

Revenue And Margin Collapse

Sharp revenue deterioration combined with negative gross profit indicates that current service economics are not covering the cost of delivery. Unless the trend reverses, weak scale and unfavorable margins can limit reinvestment, erode operating leverage, and prolong dependence on external capital.

Persistent Cash Burn

Ongoing operating and free-cash-flow losses show that the business is consuming cash rather than funding itself. This reduces financial resilience and leaves iSpecimen reliant on financing or other capital access to sustain operations, pursue growth, and absorb continued execution setbacks.

Dilution And Listing Risk

The company’s need for equity-linked financing can dilute existing holders and may reflect limited internal funding capacity. At the same time, unresolved Nasdaq equity compliance creates a structural corporate risk, because failure to meet requirements could impair access to public capital markets.

iSpecimen News

ISPC FAQ

What was iSpecimen’s price range in the past 12 months?
iSpecimen lowest stock price was $0.56 and its highest was $27.45 in the past 12 months.
What is iSpecimen’s market cap?
iSpecimen’s market cap is $3.45M.
When is iSpecimen’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were iSpecimen’s earnings last quarter?
iSpecimen released its earnings results on Oct 29, 2026. The company reported -$1.026 earnings per share for the quarter.
Is iSpecimen overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does iSpecimen pay dividends?
iSpecimen does not currently pay dividends.
What is iSpecimen’s EPS estimate?
iSpecimen’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does iSpecimen have?
iSpecimen has 5,789,013 shares outstanding.
What happened to iSpecimen’s price movement after its last earnings report?
iSpecimen reported an EPS of -$1.026 in its last earnings report. Following the earnings report the stock price went down -9.382%.
Which hedge fund is a major shareholder of iSpecimen?
Hedge funds hold iSpecimen shares: the largest hedge-fund position in iSpecimen is 71,883,397 shares.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology